Not logged in, please login to view portfolio!

Sarmaaya Trainings


SAPL Share Price | Sanofi-Aventis Pakistan Limited

SAPL Share Price History

SAPL (Sanofi-Aventis Pakistan Limited) listed in PSX,ALLSHR,KMIALLSHR. SAPL share price / stock price today is 1,198.00 PKR. Today volume traded in SAPL is 50, price change is 4.27%, high price is 1198.00 PKR, and low price is 1198.00 PKR.

Company Snapshot

loading
SAPL
2022-09-30 11:55:34
Current
1,198.00
Change
49.00
Change %
4.27%
Volume
50
Price to Earnings Ratio
17.75
Earning per Share
67.49
Book Value
519.24
Price to Book
2.06
Market Cap
11.55 B
Dividend
30.00
Dividend Yield (%)
2.81 %
Debt to Equity
0.00
Net Profit Margin
3.76 %
Gross Profit Margin
28.80 %
Current Ratio
1.61
Face Value
10.00
Shares
9.64 M
FreeFloat
1.45 M
Free Float %
15.00
Equity to Asset(%)
48.90
Interest
56.34
Beta
0.51
Upper Cap
1,235.18
Lower Cap
1,062.83
52 Week High
1540.00
52 Week Low
492.00
High
1198.00
Low
1198.00
Previous
1149.00
loading

Company Brands

image
image
image
image
image
SAPL Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -2.522% -11.391% 20.544% 33.259% 66.852%

Company Financials
Company Announcements
Date Announce Title Attachments
2022-09-16 Notice of Extraordinary General Meeting View PDF
2022-09-15 Notice of Extraordinary General Meeting (Pre-Publication) View PDF
2022-08-31 Transmission of Financial Statements for the half-year ended June 30, 2022 View PDF
2022-08-25 Financial results for the half year ended June 30, 2022 View PDF
2022-08-17 Board Meeting for the half year ended June 30, 2022 View PDF
2022-08-16 Disclosure of Material information View PDF
2022-07-21 Notice of Book Closure View PDF
2022-06-29 Material Information View PDF
2022-05-06 Material Information View PDF
2022-05-06 Credit of Final Cash Dividend for the Year 2021 View PDF
2022-04-28 Financial Results for the Quarter Ended March 31, 2022 View PDF
2022-04-28 Material Information View PDF
2022-04-25 Certified Extract of Resolutions passed at 54th Annual General Meeting View PDF
2022-04-04 Notice of Annual General Meeting for the Year Ended December 31, 2021 View PDF
2022-04-01 Transmission of Annual Report for the Year Ended December 31, 2021 View PDF
2022-03-17 Board Meeting for the Year ended December 31, 2021 View PDF
2021-12-30 Material Information View PDF
2021-12-28 Material Information View PDF
2021-12-20 Material Information View PDF
2021-11-22 Change of Company Secretary View
2021-10-28 Transmission of Financial Statements for Period Ended September 30, 2021 View PDF
2021-10-27 Financial Results for the Period Ended September 30, 2021 View PDF
2021-10-14 Board Meeting for the Period Ended September 30, 2021 View PDF
2021-08-27 SAPL Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2021 Financial Statements View PDF
2021-08-26 Financial Results for the Six Months Ended June 30, 2021 View PDF
2021-08-17 Board Meeting View PDF
2021-05-05 Credit of Final Cash Dividend for the Year 2020 View PDF
2021-04-30 SAPL | Sanofi-Aventis Pakistan Limited - Transmission of Quarterly Report for the period ended March 31, 2021 PDF
2021-04-30 Transmission of Quarterly Accounts for the Period Ended March 31, 2021 View PDF
2021-04-28 Financial Results for the Quarter Ended March 31, 2021 View PDF
2021-04-23 Certified Extract of Resolutions passed at 53rd Annual General Meeting View PDF
2021-04-19 Board Meeting for the Quarter ended March 31, 2021 View PDF
2021-03-30 Transmission of Annual Report for the Year Ended December 31, 2020 View PDF
2021-03-30 Notice of Annual General Meeting for the Year Ended December 31, 2020 View PDF
2021-03-02 Financial Results for the Year Ended December 31, 2020 View PDF
2021-02-18 Board Meeting for the Year ended December 31, 2020 View PDF

About Company

Sanofi-aventis Pakistan Limited was incorporated in Pakistan in 1967 as a Public Limited Company. The Company is a subsidiary of Sanofi Foreign Participations B.V., registered in Netherlands (the Parent Company). The Ultimate Parent of the Company is Sanofi S.A., France. It is engaged in the manufacturing and selling of pharmaceutical, consumer healthcare products and vaccines.

Address
Plot No 23, Sector 22 Korangi In
Website
www.sanofi.com.pk
Key People
Mr.Syed Babar Ali Chairperson
Mr.Asim Jamal CEO
Mr.Muhammad Yousaf Company Secretary

Page description

SAPL (Sanofi-Aventis Pakistan Limited) listed in PSX,ALLSHR,KMIALLSHR. SAPL Share Price / Stock Price is 1,198.00 PKR. You can also check; Share Price History, SAPLPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

SAPL Share Price SAPL Stock Price Sanofi-Aventis Pakistan Limited psx stock kse100 stock SAPL Stock Price ALLSHR KMIALLSHR Share price History SAPL Payouts Annoucements Snapshot SAPL Address SAPL CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages SAPL Chairperson SAPL Secretary SAPL Website About SAPL

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

If you are someone who is keen on investments but does not have the time to research, identify stock market patterns, and keep track of stocks, forex, mutual funds, cryptocurrencies and other commodities like Gold and silver, then Sarmaaya is your meeting place, the crossroads where you can find everything you need to make the best decisions in the trading market. Based on unbiased, accurate and free information.

© 2022 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.